FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:438-439 August 8, 2002 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Little, S. J. PubMed Citation

In the resource-rich countries, a remarkable success story has emerged during the past decade in the treatment of human immunodeficiency virus (HIV) infections. There has been strikingly reduced morbidity and mortality among patients treated with potent combination antiretroviral regimens. This success, however, has not been without consequences, the most serious of which are toxic effects associated with current regimens and development of resistance to antiretroviral drugs. In this issue of the Journal, Little et al.¹ report that in North America, the proportion of new HIV infections with some degree of drug resistance is increasing. This finding is based on a . . . [Full Text of this Article]

This article has been cited by other articles:

• Weinberg, A., Quinones-Mateu, M.E., Lederman, M.M. (2006). Role of Human {beta}-defensins in HIV Infection. ADR 19: 42-48 [Abstract] [Full Text]  
• (2002). More on Transmission of Drug-Resistant Virus. AIDS Clin Care 2002: 3-3 [Full Text]  
• (2002). Transmission of Resistant HIV on the Rise. JWatch Infect. Diseases 2002: 4-4 [Full Text]